Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure
Viruses · 2023
DOI: 10.3390/v15010229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Marion Ferren und 7 weiteren Autor:innen. Beteiligte Einrichtung: CIRI, Centre International de Recherche en Infectiologie, Team Neuro-Invasion, TROpism and VIRal Encephalitis, Université de Lyon, Inserm, U1111, CNR…. Hauptthemen laut MEDLINE: Central Nervous System, Measles, Measles virus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NIH.
Abstract (Originalsprache)
The cessation of measles virus (MeV) vaccination in more than 40 countries as a consequence of the COVID-19 pandemic is expected to significantly increase deaths due to measles. MeV can infect the central nervous system (CNS) and lead to lethal encephalitis. Substantial part of virus sequences recovered from patients’ brain were mutated in the matrix and/or the fusion protein (F). Mutations of the heptad repeat domain located in the C terminal (HRC) part of the F protein were often observed and were associated to hyperfusogenicity. These mutations promote brain invasion as a hallmark of neuroadaptation. Wild-type F allows entry into the brain, followed by limited spreading compared with the massive invasion observed for hyperfusogenic MeV. Taking advantage of our ex vivo models of hamster organotypic brain cultures, we investigated how the hyperfusogenic mutations in the F HRC domain modulate virus distribution in CNS cells. In this study, we also identified the dependence of neural cells susceptibility on both their activation state and destabilization of the virus F protein. Type I interferon (IFN-I) impaired mainly astrocytes and microglial cells permissiveness contrarily to neurons, opening a new way of consideration on the development of treatments against viral encephalitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIRI, Centre International de Recherche en Infectiologie, Team Neuro-Invasion, TROpism and VIRal Encephalitis, Université de Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure…
- CIRI, Centre International de Recherche en Infectiologie, Team Immunobiology of the Viral infections, Université de Lyon, Inserm, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon,…
- Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
- Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli," 81100 Caserta, Italy.
ORCID-Profile: Marion Ferren, Alexandre Lalande, Mathieu Iampietro, Denis Gerlier, Cyrille Mathieu
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NIH
- French ANR NITRODEP
- C.M.
Zitieren
APA
Ferren, M., Lalande, A., Iampietro, M., Canus, L., Decimo, D., Gerlier, D., Porotto, M., & Mathieu, C. (2023). Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure. Viruses. https://doi.org/10.3390/v15010229
Vancouver
Ferren M, Lalande A, Iampietro M, Canus L, Decimo D, Gerlier D, et al. Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure. Viruses. 2023. doi:10.3390/v15010229
BibTeX
@article{Ferren2023,
author = {Ferren, Marion and Lalande, Alexandre and Iampietro, Mathieu and Canus, Lola and Decimo, Didier and Gerlier, Denis and Porotto, Matteo and Mathieu, Cyrille},
title = {Early Permissiveness of Central Nervous System Cells to Measles Virus Infection Is Determined by Hyperfusogenicity and Interferon Pressure},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010229}
}
EUVIMED